| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.01B | 6.14B | 5.78B | 5.66B | 6.01B | 8.40B |
| Gross Profit | 4.74B | 4.88B | 4.53B | 4.52B | 4.97B | 7.13B |
| EBITDA | 1.54B | 1.62B | 1.35B | 1.39B | 1.37B | 3.74B |
| Net Income | 837.81M | 898.61M | 698.94M | 762.99M | 671.95M | 2.43B |
Balance Sheet | ||||||
| Total Assets | 7.50B | 7.50B | 6.91B | 6.67B | 7.38B | 9.04B |
| Cash, Cash Equivalents and Short-Term Investments | 4.80B | 5.02B | 4.19B | 4.13B | 4.08B | 5.80B |
| Total Debt | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M | 200.00M |
| Total Liabilities | 1.46B | 1.38B | 1.29B | 1.30B | 1.30B | 1.63B |
| Stockholders Equity | 6.05B | 6.12B | 5.61B | 5.37B | 6.08B | 7.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.51B | 763.11M | 1.52B | 260.71M | 2.12B |
| Operating Cash Flow | 0.00 | 1.55B | 773.14M | 1.83B | 618.54M | 2.60B |
| Investing Cash Flow | 0.00 | -303.59M | -271.66M | -295.02M | -336.96M | -537.22M |
| Financing Cash Flow | 0.00 | -408.36M | -444.12M | -1.47B | -2.01B | -1.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥24.43B | 20.79 | ― | 3.50% | 11.96% | 10.15% | |
72 Outperform | ¥13.32B | 13.86 | ― | 2.91% | 6.19% | 28.57% | |
72 Outperform | ¥31.09B | 10.82 | ― | 4.39% | 17.36% | 0.17% | |
71 Outperform | ¥23.32B | 8.30 | ― | 2.18% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥6.63B | 13.18 | ― | ― | 11.62% | ― | |
52 Neutral | ¥1.82B | 23.80 | ― | ― | 19.02% | 15.39% |